187 related articles for article (PubMed ID: 11474082)
1. Genetics. SNP-ing drugs to size.
Gura T
Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
[No Abstract] [Full Text] [Related]
2. CYP3A genetics in drug metabolism.
Eichelbaum M; Burk O
Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
[No Abstract] [Full Text] [Related]
3. Effects of disease on expression and regulation of CYPs.
Farrell G
Mol Aspects Med; 1999; 20(1-2):55-70, 137. PubMed ID: 10575652
[No Abstract] [Full Text] [Related]
4. Is there a role for nuclei in the metabolism of xenobiotica? A review.
Romano M; Facchinetti T; Salmona M
Drug Metab Rev; 1983; 14(4):803-29. PubMed ID: 6413186
[No Abstract] [Full Text] [Related]
5. In vitro and in vivo drug interactions involving human CYP3A.
Thummel KE; Wilkinson GR
Annu Rev Pharmacol Toxicol; 1998; 38():389-430. PubMed ID: 9597161
[TBL] [Abstract][Full Text] [Related]
6. Erythromycin breath test.
Watkins PB
Clin Pharmacol Ther; 2000 May; 67(5):577-8. PubMed ID: 10824637
[No Abstract] [Full Text] [Related]
7. [Molecular mechanism of the expression and modulation of CYP3A gene].
Wang JS; Zhou HH
Sheng Li Ke Xue Jin Zhan; 1998 Apr; 29(2):173-6. PubMed ID: 12501692
[No Abstract] [Full Text] [Related]
8. Grapefruits and drugs: when is statistically significant clinically significant?
Abernethy DR
J Clin Invest; 1997 May; 99(10):2297-8. PubMed ID: 9153265
[No Abstract] [Full Text] [Related]
9. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
Chiou WL; Jeong HY; Wu TC; Ma C
Clin Pharmacol Ther; 2001 Oct; 70(4):305-10. PubMed ID: 11673745
[No Abstract] [Full Text] [Related]
10. Cisapride (Prepulsid): interactions with grapefruit and drugs.
Morawiecka I
CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
[No Abstract] [Full Text] [Related]
11. Thin-layer chromatographic analysis of human CYP3A-catalyzed testosterone 6 beta-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 1998; 107():153-61. PubMed ID: 14577225
[No Abstract] [Full Text] [Related]
12. Pharmacology. A worrisome side effect of an antianxiety remedy.
Vogel G
Science; 2001 Jan; 291(5501):37. PubMed ID: 11192003
[No Abstract] [Full Text] [Related]
13. Editorial: in this issue.
Prakash C
Curr Drug Metab; 2008 Jun; 9(5):361-2. PubMed ID: 18537572
[No Abstract] [Full Text] [Related]
14. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
Martínez C; García-Martín E; Pizarro RM; García-Gamito FJ; Agúndez JA
Br J Cancer; 2002 Sep; 87(6):681-6. PubMed ID: 12237780
[TBL] [Abstract][Full Text] [Related]
15. Amlodipine has a minor effect on cyclosporine metabolism.
McGregor DO; Bailey RR; Robson RA
Clin Nephrol; 1997 Nov; 48(5):336. PubMed ID: 9403222
[No Abstract] [Full Text] [Related]
16. Pharmacology. How the body's 'garbage disposal' may inactivate drugs.
Vogel G
Science; 2001 Jan; 291(5501):35-7. PubMed ID: 11192002
[No Abstract] [Full Text] [Related]
17. A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation.
Ariyoshi N; Miyazaki M; Toide K; Sawamura Yi ; Kamataki T
Biochem Biophys Res Commun; 2001 Mar; 281(5):1256-60. PubMed ID: 11243870
[TBL] [Abstract][Full Text] [Related]
18. On the assessment of effects of food on the pharmacokinetics of drugs in early development.
Li Z; Vachharajani NN; Krishna R
Biopharm Drug Dispos; 2002 May; 23(4):165-71. PubMed ID: 12015791
[TBL] [Abstract][Full Text] [Related]
19. Nuclear xeno-sensors as receptors for cholestatic bile acids: the second line of defense.
Bock HH; Lammert F
Hepatology; 2002 Jan; 35(1):232-4. PubMed ID: 11786981
[No Abstract] [Full Text] [Related]
20. CYP3A in horse intestines.
Tydén E; Olsén L; Tallkvist J; Larsson P; Tjälve H
Toxicol Appl Pharmacol; 2004 Dec; 201(2):112-9. PubMed ID: 15541751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
